Artificial intelligence (AI) is now everywhere. It’s in our web browsers, deliveries, our phones, and even our healthcare systems. Yet it’s the latter that could be one of the best opportunities out there for the next AI winner. And it could be a Canadian company.
So today, let’s look at why healthcare stocks invested in AI could be your next great investment, and why WELL Health Technologies (TSX:WELL) is the perfect stock to watch.
Healthy AI
First, let’s look at why AI in healthcare is such a winning scenario. AI in healthcare has the potential to be one of the biggest investment stories out there. That’s because it’s already reshaping an industry that literally touches everyone. Unlike some tech fad, healthcare is essential. And AI can be essential in the way that it can lower costs, save lives, and unlock massive efficiencies.
For instance, healthcare drowns in data from medical records to lab results and everything in between. AI is the best place to use that data, as it can analyze patterns fast and efficiently. Then it can make use of that data for diagnosis, drug discovery, treatments, you name it. And in an aging population around the globe, the faster and cheaper we can provide healthcare, the better.
What’s more, money is already flowing in. Tech giants invest billions in partnerships with hospitals and pharmaceutical companies to get into AI. That’s because healthcare is an essential service, as we saw during the pandemic, and one that’s not going to disappear any time soon.
Why WELL Health works
For investors looking to AI in healthcare, WELL is a superior opportunity. The stock is a growth story in Canadian healthcare, but also in Canadian stocks, hitting record after record quarter. The AI stock just delivered a 57% year-over-year revenue growth record of $356.7 million. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) also tripled, showing the stock is exactly what long-term investors want.
Plus, it’s shifting from pure clinic to a diversified healthcare technology platform. Its software-as-a-service (SaaS) business, WELLSTAR, is on pace for over $100 million in annual revenue. Plus, HEALWELL is ramping up AI and data science, contributing $40 million during the second quarter.
More is on the way as well, with over one million Canadian patient visits achieved for the first time. That’s up 38% year-over-year. Of course, all the expansion means debt, which sits at $621 million. However, the stock is quickly working towards organic growth. And that’s exactly what long-term investors want to hear.
Bottom line
If you’re an investor hoping to get into AI stocks, then WELL could be one that belongs on your watchlist. The healthcare stock continues to surge each and every quarter, making it a high-risk, but certainly high reward investment. And that’s far better than what can be said for tech names in the AI industry. For investors who can therefore tolerate some volatility, this could be the chance to get in on AI in an essential sector.
